The chart below shows how CMPO performed 10 days before and after its earnings report, based on data from the past quarters. Typically, CMPO sees a +0.87% change in stock price 10 days leading up to the earnings, and a +9.42% change 10 days following the report. On the earnings day itself, the stock moves by -2.16%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Sales Increase Performance: 1. Strong Sales Growth: CompoSecure reported a net sales increase of 11% in Q3 2024, reaching $107.1 million compared to $96.9 million in the prior year, driven by strong international performance.
Adjusted EBITDA Increase: 2. Improved Adjusted EBITDA: Adjusted EBITDA rose by 13% to $40 million in Q3 2024, with an adjusted EBITDA margin of 37.3%, reflecting operational efficiencies and cost management.
Gross Profit Improvement: 3. Increased Gross Profit: Gross profit for Q3 2024 increased by 13% to $26 million, with gross margins improving to 52% from 51% in the previous year due to a favorable product mix.
Strong Cash Generation: 4. Positive Cash Flow: Year-to-date net cash provided by operating activities was $94 million, up 21% compared to the same period last year, indicating strong cash generation capabilities.
Contract Extension Secured: 5. Contract Extension with Capital One: CompoSecure secured a 2-year contract extension with Capital One, demonstrating customer trust and commitment to delivering differentiated products at scale.
Negative
GAAP Net Loss Analysis: 1. GAAP Net Loss: CompoSecure reported a GAAP net loss of $108 million in Q3 2024, primarily due to non-cash fair value adjustments, contrasting sharply with a $6 million non-cash benefit in the same quarter last year.
Sales Guidance Revision: 2. Revised Sales Guidance: The company revised its 2024 net sales guidance down to a range of $418 million to $424 million, indicating a slowdown compared to previous expectations and reflecting a deceleration in growth.
Future Growth Expenses: 3. Increased Expenses for Future Growth: The fourth quarter is expected to incur one-time non-recurring professional expenses of $4 million to $6 million, which will impact adjusted EBITDA, reflecting the costs associated with building M&A capabilities.
2025 Sales Growth Outlook: 4. Lowered 2025 Sales Growth Expectations: Early projections for 2025 suggest that sales growth could be lower than in 2024, indicating potential challenges in maintaining momentum in the upcoming year.
Debt Burden Concerns: 5. High Debt Levels: As of September 30, 2024, CompoSecure had total debt of $330 million, which poses a significant financial burden, despite a slight reduction from $340.3 million at the end of 2023.
CompoSecure, Inc. (CMPO) Q3 2024 Earnings Call Transcript
CMPO.O
-4.73%